Inovio receives u.s. fda's orphan drug designation for rare disease treatment

Inovio receives orphan drug designation from u.s. fda for dna medicine ino-3107 to treat rare disease recurrent respiratory papillomatosis (rrp).
INO Ratings Summary
INO Quant Ranking